Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 32

1.

Reply.

Simon M, Pariente B.

Clin Gastroenterol Hepatol. 2016 Sep 17. pii: S1542-3565(16)30674-7. doi: 10.1016/j.cgh.2016.09.016. [Epub ahead of print] No abstract available.

PMID:
27650327
2.

Ulcerative proctitis is a frequent location of paediatric-onset UC and not a minor disease: a population-based study.

Hochart A, Gower-Rousseau C, Sarter H, Fumery M, Ley D, Spyckerelle C, Peyrin-Biroulet L, Laberenne JE, Vasseur F, Savoye G, Turck D; Epimad Group.

Gut. 2016 Aug 3. pii: gutjnl-2016-311970. doi: 10.1136/gutjnl-2016-311970. [Epub ahead of print]

PMID:
27489240
3.

Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study.

Cheddani H, Dauchet L, Fumery M, Charpentier C, Marie Bouvier A, Dupas JL, Pariente B, Peyrin-Biroulet L, Savoye G, Gower-Rousseau C.

Am J Gastroenterol. 2016 Aug 2. doi: 10.1038/ajg.2016.304. [Epub ahead of print]

PMID:
27481308
4.

Endoscopic Detection of Small Bowel Dysplasia and Adenocarcinoma in Crohn's Disease: A Prospective Cohort-Study in High-Risk Patients.

Simon M, Cosnes J, Gornet JM, Seksik P, Stefanescu C, Blain A, Pariente B, Nancey S, Vuitton L, Nachury M, D'Haens G, Filippi J, Chevret S, Laharie D; GETAID group.

J Crohns Colitis. 2016 Jul 12. pii: jjw123. [Epub ahead of print]

PMID:
27405958
5.

Ileal or Anastomotic Location of Lesions Does Not Impact Rate of Postoperative Recurrence in Crohn's Disease Patients Classified i2 on the Rutgeerts Score.

Bayart P, Duveau N, Nachury M, Zerbib P, Gerard R, Branche J, Maunoury V, Wils P, Boruchowicz A, Boualit M, Laberenne JE, Manolache O, Desreumaux P, de Chambrun GP, Pariente B.

Dig Dis Sci. 2016 Oct;61(10):2986-92. doi: 10.1007/s10620-016-4215-1. Epub 2016 Jul 11.

PMID:
27401274
6.

Natural History of Crohn's Disease in Elderly Patients Diagnosed Over the Age of 70 Years: A Population-Based Study.

Fumery M, Pariente B, Sarter H, Charpentier C, Armengol Debeir L, Dupas JL, Coevoet H, Peyrin-Biroulet L, dʼAgay L, Gower-Rousseau C, Savoye G; EPIMAD group.

Inflamm Bowel Dis. 2016 Jul;22(7):1698-707. doi: 10.1097/MIB.0000000000000821.

PMID:
27206018
7.

Reply.

Pariente B, Wils P, Laharie D.

Gastroenterology. 2016 May;150(5):1239. doi: 10.1053/j.gastro.2016.03.022. Epub 2016 Mar 25. No abstract available.

PMID:
27020336
8.

Effectiveness and Safety of Vedolizumab Induction Therapy for Patients With Inflammatory Bowel Disease.

Amiot A, Grimaud JC, Peyrin-Biroulet L, Filippi J, Pariente B, Roblin X, Buisson A, Stefanescu C, Trang-Poisson C, Altwegg R, Marteau P, Vaysse T, Bourrier A, Nancey S, Laharie D, Allez M, Savoye G, Moreau J, Gagniere C, Vuitton L, Viennot S, Aubourg A, Pelletier AL, Bouguen G, Abitbol V, Bouhnik Y; Observatory on Efficacy and of Vedolizumab in Patients With Inflammatory Bowel Disease Study Group and the Groupe d'Etude Therapeutique des Affections Inflammatoires du tube Digestif.

Clin Gastroenterol Hepatol. 2016 Feb 22. pii: S1542-3565(16)00164-6. doi: 10.1016/j.cgh.2016.02.016. [Epub ahead of print]

PMID:
26917043
9.

Validation of the Inflammatory Bowel Disease Disability Index in a population-based cohort.

Gower-Rousseau C, Sarter H, Savoye G, Tavernier N, Fumery M, Sandborn WJ, Feagan BG, Duhamel A, Guillon-Dellac N, Colombel JF, Peyrin-Biroulet L; and the International Programme to Develop New Indexes for Crohn's Disease (IPNIC) group; International Programme to Develop New Indexes for Crohn's Disease IPNIC group.

Gut. 2015 Dec 8. pii: gutjnl-2015-310151. doi: 10.1136/gutjnl-2015-310151. [Epub ahead of print]

PMID:
26646934
10.

Long-term Outcomes of Thalidomide Therapy for Adults With Refractory Crohn's Disease.

Simon M, Pariente B, Lambert J, Cosnes J, Bouhnik Y, Marteau P, Allez M, Colombel JF, Gornet JM.

Clin Gastroenterol Hepatol. 2016 Jul;14(7):966-972.e2. doi: 10.1016/j.cgh.2015.10.034. Epub 2015 Nov 18.

PMID:
26598226
11.

Subcutaneous Ustekinumab Provides Clinical Benefit for Two-Thirds of Patients With Crohn's Disease Refractory to Anti-Tumor Necrosis Factor Agents.

Wils P, Bouhnik Y, Michetti P, Flourie B, Brixi H, Bourrier A, Allez M, Duclos B, Grimaud JC, Buisson A, Amiot A, Fumery M, Roblin X, Peyrin-Biroulet L, Filippi J, Bouguen G, Abitbol V, Coffin B, Simon M, Laharie D, Pariente B; Groupe d'Etude Thérapeutique des Affections Inflammatoires du Tube Digestif.

Clin Gastroenterol Hepatol. 2016 Feb;14(2):242-50.e1-2. doi: 10.1016/j.cgh.2015.09.018. Epub 2015 Sep 30.

PMID:
26432476
12.

Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.

Peyrin-Biroulet L, Sandborn W, Sands BE, Reinisch W, Bemelman W, Bryant RV, D'Haens G, Dotan I, Dubinsky M, Feagan B, Fiorino G, Gearry R, Krishnareddy S, Lakatos PL, Loftus EV Jr, Marteau P, Munkholm P, Murdoch TB, Ordás I, Panaccione R, Riddell RH, Ruel J, Rubin DT, Samaan M, Siegel CA, Silverberg MS, Stoker J, Schreiber S, Travis S, Van Assche G, Danese S, Panes J, Bouguen G, O'Donnell S, Pariente B, Winer S, Hanauer S, Colombel JF.

Am J Gastroenterol. 2015 Sep;110(9):1324-38. doi: 10.1038/ajg.2015.233. Epub 2015 Aug 25. Review.

PMID:
26303131
13.

Changes in the Lémann Index Values During the First Years of Crohn's Disease.

Gilletta C, Lewin M, Bourrier A, Nion-Larmurier I, Rajca S, Beaugerie L, Sokol H, Pariente B, Seksik P, Cosnes J.

Clin Gastroenterol Hepatol. 2015 Sep;13(9):1633-40.e3. doi: 10.1016/j.cgh.2015.02.041. Epub 2015 Mar 10.

PMID:
25766650
14.

Functional TP53 mutations have no impact on response to cytotoxic agents in metastatic colon cancer.

Netter J, Lehmann-Che J, Lambert J, Tallet A, Lourenco N, Soliman H, Bertheau P, Pariente B, Chirica M, Pocard M, Allez M, De The H, Gornet JM.

Bull Cancer. 2015 Feb;102(2):117-25. doi: 10.1016/j.bulcan.2014.12.010. Epub 2015 Jan 20.

15.

Benefit of infliximab reintroduction after successive failure of infliximab and adalimumab in Crohn's disease.

Gagniere C, Beaugerie L, Pariente B, Seksik P, Amiot A, Abitbol V, Allez M, Cosnes J, Sokol H.

J Crohns Colitis. 2015 Apr;9(4):349-55. doi: 10.1093/ecco-jcc/jju024. Epub 2014 Dec 28.

PMID:
25547977
16.

Development of the Lémann index to assess digestive tract damage in patients with Crohn's disease.

Pariente B, Mary JY, Danese S, Chowers Y, De Cruz P, D'Haens G, Loftus EV Jr, Louis E, Panés J, Schölmerich J, Schreiber S, Vecchi M, Branche J, Bruining D, Fiorino G, Herzog M, Kamm MA, Klein A, Lewin M, Meunier P, Ordas I, Strauch U, Tontini GE, Zagdanski AM, Bonifacio C, Rimola J, Nachury M, Leroy C, Sandborn W, Colombel JF, Cosnes J.

Gastroenterology. 2015 Jan;148(1):52-63.e3. doi: 10.1053/j.gastro.2014.09.015. Epub 2014 Sep 21.

PMID:
25241327
17.

Endoscopic and clinical recurrences after laparoscopic or open ileocolic resection in Crohn's disease.

Bellinger J, Munoz-Bongrand N, Pariente B, Baudry C, Chirica M, Gornet JM, Allez M, Cattan P.

J Laparoendosc Adv Surg Tech A. 2014 Sep;24(9):617-22. doi: 10.1089/lap.2014.0121.

PMID:
25192247
18.

Computed tomography evaluation of high-grade esophageal necrosis after corrosive ingestion to avoid unnecessary esophagectomy.

Chirica M, Resche-Rigon M, Pariente B, Fieux F, Sabatier F, Loiseaux F, Munoz-Bongrand N, Gornet JM, Brette MD, Sarfati E, Azoulay E, Zagdanski AM, Cattan P.

Surg Endosc. 2015 Jun;29(6):1452-61. doi: 10.1007/s00464-014-3823-0. Epub 2014 Aug 27.

PMID:
25159655
19.

Tailored treatment according to early post-surgery colonoscopy reduces clinical recurrence in Crohn's disease: a retrospective study.

Baudry C, Pariente B, Lourenço N, Simon M, Chirica M, Cattan P, Munoz-Bongrand N, Gornet JM, Allez M.

Dig Liver Dis. 2014 Oct;46(10):887-92. doi: 10.1016/j.dld.2014.07.005. Epub 2014 Jul 28.

PMID:
25081846
20.

Review article: why, when and how to de-escalate therapy in inflammatory bowel diseases.

Pariente B, Laharie D.

Aliment Pharmacol Ther. 2014 Aug;40(4):338-53. doi: 10.1111/apt.12838. Epub 2014 Jun 23. Review.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk